Breakthrough in COVID research: link between immune cells and long COVID - Innovation Origins

Researchers the University of Manchester ester have found ab first l behaviour in monocytes.

This could be used as drug targets for treating long-COVID symptoms.

Lo COVID VID can lead to debilitating symptoms such as extreme fatigue The University of Manchester si Manchester University NHS Foundation Trust sc MFT r d Northern Care Alliance Foundation Trust r NCA n year the National Institute for Health and Care Research hL NIHR Text__NxlGi">first Conclusion S1 first yFeed_high Elizabeth Mann Gi University of Manchester class="summaryFeed_highLightText__NxlGi">mono monocyte an> COVID-19 ghtText__NxlGi">COVID-19 first lass="summaryFeed_highLightText__NxlGi">COVID-19 the European Respiratory Journal xlGi">first 71 span> COVID-19 ext__ 142 Gi">years months t__NxlGi">months COVID-19 ummaryFeed_highLightText__NxlGi">myalgia< monocyte Dr Mann up to nine months